Multi tyrosine kinase inhibitor dasatinib as novel cause of pulmonary artery hypertension ?
暂无分享,去创建一个
C. Bokemeyer | T. Brümmendorf | H. Baumann | H. Klose | F. Honecker | Gunhild Keller | S. Kluge | J. K. Hennigs
[1] J. Seymour,et al. Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia. , 2009, Leukemia research.
[2] F. Orzan,et al. Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient , 2009, Bone Marrow Transplantation.
[3] M. Humbert,et al. Pulmonary Hypertension Associated with Myeloproliferative Disorders: A Retrospective Study of Ten Cases , 2007, Respiration.
[4] Gerhard Dürnberger,et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. , 2007, Blood.
[5] J. Pinson,et al. Recurrence of severe pulmonary hypertension following the removal of a lung allograft. , 2007, Chest.
[6] V. Meignin,et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. , 2007, American journal of respiratory and critical care medicine.
[7] R. Munden,et al. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Ricachinevsky,et al. Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.
[9] M. Humbert,et al. Reduced exercise capacity in a mouse model of asthma , 2006, Thorax.
[10] H. Farber,et al. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. , 2006, Annals of internal medicine.
[11] W. Seeger,et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. , 2005, The Journal of clinical investigation.
[12] W. Seeger,et al. Imatinib for the treatment of pulmonary arterial hypertension. , 2005, The New England journal of medicine.
[13] E. K. Weir,et al. Anorectic drugs and pulmonary hypertension from the bedside to the bench. , 2001, The American journal of the medical sciences.